According to the American Association for the Study of Liver Diseases (AASLD) Practice Guidance, it recommends HCC surveillance using a combination of liver ultrasound and AFP with a sensitivity in detecting early-stage HCC of 63% (95% CI, 48%-75%) (Figure 1). Here, AFP is linked to hepatocellular carcinoma.